miércoles, 11 de mayo de 2011

National Guideline Clearinghouse | American Cancer Society guideline for the early detection of prostate cancer.



Guideline Title
American Cancer Society guideline for the early detection of prostate cancer.

Bibliographic Source(s)
Wolf AM, Wender RC, Etzioni RB, Thompson IM, D'Amico AV, Volk RJ, Brooks DD, Dash C, Guessous I, Andrews K, DeSantis C, Smith RA, American Cancer Society Prostate Cancer Advisory Committee. American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin 2010 Mar-Apr;60(2):70-98. [154 references] PubMed


Guideline Status
This is the current release of the guideline.

This guideline updates previous versions:

Recommendations from the American Cancer Society Workshop on Early Prostate Cancer Detection, May 4-6, 2000 and ACS guideline on testing for early prostate cancer detection: update 2001. CA Cancer J Clin 2001 Jan-Feb;51(1):39-44.

Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2003. CA Cancer J Clin 2003 Jan-Feb;53(1):27-43.

Each year the American Cancer Society publishes a summary of existing recommendations for early cancer detection, including updates, and/or emerging issues that are relevant to screening for cancer.

full-text:
National Guideline Clearinghouse | American Cancer Society guideline for the early detection of prostate cancer.




CA Cancer J Clin. 2010 Mar-Apr;60(2):70-98. Epub 2010 Mar 3.
American Cancer Society guideline for the early detection of prostate cancer: update 2010.
Wolf AM, Wender RC, Etzioni RB, Thompson IM, D'Amico AV, Volk RJ, Brooks DD, Dash C, Guessous I, Andrews K, DeSantis C, Smith RA; American Cancer Society Prostate Cancer Advisory Committee.
Collaborators (15)Wolf AM, Baquet CR, Chodak G, Cook J, D'Amico AV, Etzioni RB, Fogel TD, Godley PA, LeBlanc CM, Mason T, Master V, Salner AL, Simons VH, Thompson IM Jr, Wender RC.

Source
University of Virginia School of Medicine, Charlottesville, VA, USA
.

Abstract
In 2009, the American Cancer Society (ACS) Prostate Cancer Advisory Committee began the process of a complete update of recommendations for early prostate cancer detection. A series of systematic evidence reviews was conducted focusing on evidence related to the early detection of prostate cancer, test performance, harms of therapy for localized prostate cancer, and shared and informed decision making in prostate cancer screening. The results of the systematic reviews were evaluated by the ACS Prostate Cancer Advisory Committee, and deliberations about the evidence occurred at committee meetings and during conference calls. On the basis of the evidence and a consensus process, the Prostate Cancer Advisory Committee developed the guideline, and a writing committee drafted a guideline document that was circulated to the entire committee for review and revision. The document was then circulated to peer reviewers for feedback, and finally to the ACS Mission Outcomes Committee and the ACS Board of Directors for approval. The ACS recommends that asymptomatic men who have at least a 10-year life expectancy have an opportunity to make an informed decision with their health care provider about screening for prostate cancer after they receive information about the uncertainties, risks, and potential benefits associated with prostate cancer screening. Prostate cancer screening should not occur without an informed decision-making process. Men at average risk should receive this information beginning at age 50 years. Men in higher risk groups should receive this information before age 50 years. Men should either receive this information directly from their health care providers or be referred to reliable and culturally appropriate sources. Patient decision aids are helpful in preparing men to make a decision whether to be tested.

Copyright 2010 American Cancer Society, Inc.

Comment in
CA Cancer J Clin. 2010 Mar-Apr;60(2):68-9.
PMID:20200110[PubMed - indexed for MEDLINE]
Free Article
American Cancer Society guideline for the early de... [CA Cancer J Clin. 2010 Mar-Apr] - PubMed result

0 comentarios:

Publicar un comentario en la entrada